홈 › 다발성 골수종 › 플로리다 › Miami

FL Miami의 다발성 골수종 임상 시험

다발성 골수종 관련 연구 21개가 Miami 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

피험자 모집 중1/2상

University of Miami, Miami

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT04973605

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

피험자 모집 중2상

University of Miami Sylvester Comprehensive Cancer Center, Miami
University of Miami/Sylvester Cancer Institute - Alex's Place, Miami
University of Miami/Sylvester Cancer Institute - Griffin Cancer Research Building, Miami
외 2개

12세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT02693535

ERd Combination Treatment in Newly Diagnosed Multiple Myeloma (ADVANCE 2.0)

피험자 모집 중2상

University of Miami, Miami

18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06997081

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

피험자 모집 중3상

University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

피험자 모집 중2상

Miami Cancer Institute at Baptist Health, Inc., Miami

18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06297226

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

피험자 모집 중3상

Sylvester Comprehensive Cancer Center, Miami
University of Miami Hospital and Clinics, Miami
Sylvester Comprehensive Cancer Center - Kendall, Miami

18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05020236

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

피험자 모집 중3상

Sylvester Comprehensive Cancer Center, Miami
University of Miami Hospital and Clinics - Griffin Cancer Research Building, Miami
University of Miami Hospital and Clinics, Miami
외 3개

18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT06152575

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

피험자 모집 중2상

University of Miami, Miami

18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT06376526

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

피험자 모집 중1상

University of Miami Don Soffer Clinical Research Center, Miami

18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT05651932

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

피험자 모집 중1/2상

Research Site, Miami

18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05850234

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

피험자 모집 중1상

University of Miami, Miami

18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT07280013

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

피험자 모집 중4상

Sylvester Comprehensive Cancer Center, Miami
University of Miami Hospital and Clinics - Griffin Cancer Research Building, Miami
University of Miami Hospital and Clinics, Miami

18세 이상 · 모든 성별 · 2026. 7. 1. 업데이트됨 · NCT06057402